N,N-dimethyl-2-(6-(5-(trifluoromethyl)thiophen-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide

ID: ALA4531750

PubChem CID: 124176291

Max Phase: Preclinical

Molecular Formula: C16H14F3N3OS

Molecular Weight: 353.37

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)Cn1ccc2ncc(-c3ccc(C(F)(F)F)s3)cc21

Standard InChI:  InChI=1S/C16H14F3N3OS/c1-21(2)15(23)9-22-6-5-11-12(22)7-10(8-20-11)13-3-4-14(24-13)16(17,18)19/h3-8H,9H2,1-2H3

Standard InChI Key:  LPFCXGVNLRXWCM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
    4.9513  -15.9434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9501  -16.7630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6582  -17.1719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6564  -15.5346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3650  -15.9398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3698  -16.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1498  -17.0069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6272  -16.3418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1421  -15.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4069  -17.7826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2072  -17.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4642  -18.7236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7504  -17.3374    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9209  -19.3341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2645  -18.8888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2421  -17.1710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4944  -16.8395    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.9471  -17.4464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3551  -18.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1545  -17.9851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1344  -17.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8026  -16.6135    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.6536  -18.0210    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.3166  -17.3591    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 12 15  1  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
 18 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4531750

    ---

Associated Targets(Human)

GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2B (726 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grin2b Glutamate [NMDA] receptor subunit epsilon 2 (915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 353.37Molecular Weight (Monoisotopic): 353.0810AlogP: 3.87#Rotatable Bonds: 3
Polar Surface Area: 38.13Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.06CX LogP: 3.02CX LogD: 3.02
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: -1.60

References

1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA..  (2019)  1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators.,  10  (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542]
2. Chrovian CC,Soyode-Johnson A,Stenne B,Pippel DJ,Schoellerman J,Lord B,Needham AS,Xia C,Coe KJ,Sepassi K,Schoetens F,Scott B,Nguyen L,Jiang X,Koudriakova T,Balana B,Letavic MA.  (2020)  Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders.,  63  (17): [PMID:32787105] [10.1021/acs.jmedchem.9b02113]

Source